5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc; 2022. Available at: http://www.clinicalpharmacology.com. Accessed May 26, 2022.
  2. IBM Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu/ (cited: May 26, 2022). 
  3. Carisoprodol tablets package insert. Nostrum Laboratories, Inc., February 2020.
  4. Chlorzoxazone tablets package insert. Aurobindo Pharma Limited. January 2022.
  5. Cyclobenzaprine tablets package insert. Cipla USA, Inc., March 2021.
  6. Cyclobenzaprine (Fexmid®) package insert. All Pharma, LLC., January 2020.
  7. Cyclobenzaprine (Amrix®) extended-release capsule package insert. Cephalon, Inc., May 2020.
  8. Metaxalone (Skelaxin®) tablet package insert. Pfizer Laboratories Div Pfizer, Inc., April 2022.
  9. Methocarbamol tablet package insert. Camber Pharmaceuticals Inc., April 2021.
  10. Orphenadrine extended-release tablet package insert. Amneal Pharmaceuticals of New York, LLC., December 2019.
  11. Baclofen oral tablet package insert. Advagen Pharma Limited. February 2022.
  12. Baclofen oral granules (Lyvispah®) package insert. Saol Therapeutics, Inc. December 2021.
  13. Baclofen oral solution (Ozobax®) package insert. Metacel Pharmaceuticals, LLC. July 2021.
  14. Baclofen oral suspension (Fleqsuvy®) package insert. Azurity Pharmaceuticals, Inc. February 2022.
  15. Tizanidine tablets and capsules (Zanaflex®) package insert. Covis Pharma US, Inc. November 2021.
  16. Dantrolene oral capsule package insert. Amneal Pharmaceuticals of New York LLC, December 2020.
  17. Carisoprodol/ aspirin/ codeine combination oral tablet package insert. Ingenus Pharmaceuticals, LLC. December 2021.
  18. Orphenadrine/ aspirin/ caffeine (Norgesic Forte®) combination oral tablet package insert. Poly Pharmaceuticals, Inc. March 2022.  
  19. Reeves RR. Beddingfield JJ. Mack JE. Carisoprodol withdrawal syndrome. Pharmacotherapy. 2004; 24:1804-6.
  20. Reeves RR, Burke RS, Kose S. Carisoprodol: update on abuse potential and legal status. South Med J. 2012;105(11):619-23.